Long-term improvement of anaemia in a patient with aplastic anaemia by short-term administration of pegylated recombinant human megakaryocyte growth and development factor [4]

British Journal of Haematology

Volumn 125, Issue 6, 2004, Pages 818-819

  Matsuda, Akira ^a   Misumi, Motohiro ^a   Ishikawa, Maho ^a   Yagasaki, Fumiharu ^a   Jinnai, Itsuro ^a   Bessho, Masami ^a   Mizoguchi, Hideaki ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Aplastic anaemia; Haematological response; Pegylated rHuMGDF

Indexed keywords

CYCLOSPORIN A; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; THYMOCYTE ANTIBODY;

ADULT; APLASTIC ANEMIA; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LETTER; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 3042636435     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04980.x     Document Type: Letter

References (3)

1. Kizaki, M., Miyakawa, Y. & Ikeda, Y. (2003) Long-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndrome. British Journal of Haematology, 122, 764-767.
2. Tanimukai, S., Kimura, T., Sakabe, H., Ohmizono, Y., Kato, T., Miyazaki, H., Yamagishi, H. & Sonoda, Y. (1997) Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Experimental Hematology, 25, 1025-1033.
3. Yagi, M., Ritchie, K.A., Sitnicka, E., Storey, C., Roth, G.J. & Bartelmez, S. (1999) Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin. Proceedings of the National Academy of Sciences of the United States of America, 96, 8126-8131.